215 related articles for article (PubMed ID: 8523205)
1. Lamotrigine for the treatment of epilepsy in childhood.
Besag FM; Wallace SJ; Dulac O; Alving J; Spencer SC; Hosking G
J Pediatr; 1995 Dec; 127(6):991-7. PubMed ID: 8523205
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
4. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
Fitton A; Goa KL
Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
[TBL] [Abstract][Full Text] [Related]
6. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
7. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine. A review of its use in childhood epilepsy.
Culy CR; Goa KL
Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
[TBL] [Abstract][Full Text] [Related]
9. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.
Glauser TA; Cnaan A; Shinnar S; Hirtz DG; Dlugos D; Masur D; Clark PO; Adamson PC;
Epilepsia; 2013 Jan; 54(1):141-55. PubMed ID: 23167925
[TBL] [Abstract][Full Text] [Related]
10. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
[TBL] [Abstract][Full Text] [Related]
11. Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial.
Coppola G; Pascotto A
Brain Dev; 1997 Sep; 19(6):398-402. PubMed ID: 9339867
[TBL] [Abstract][Full Text] [Related]
12. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
[TBL] [Abstract][Full Text] [Related]
13. Association of lamotrigine and valproate in refractory epilepsies of children and adolescents.
Grisotto KP; Bruck I; Antoniuk SA; Santos LH
Arq Neuropsiquiatr; 2008 Sep; 66(3A):477-81. PubMed ID: 18813703
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine in absence and primary generalized epilepsies.
Mikati MA; Holmes GL
J Child Neurol; 1997 Nov; 12 Suppl 1():S29-37. PubMed ID: 9429128
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine and valproate: efficacy of co-administration in a pediatric population.
Thomé-Souza S; Freitas A; Fiore LA; Valente KD
Pediatr Neurol; 2003 May; 28(5):360-4. PubMed ID: 12878297
[TBL] [Abstract][Full Text] [Related]
16. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
[TBL] [Abstract][Full Text] [Related]
17. [Lamotrigine add-on therapy for childhood-onset refractory epilepsy: comparison of the efficacy between 3 months and 6 months after initiation].
Watanabe K; Kobayashi K; Endoh F; Yoshinaga H; Ohtsuka Y
No To Hattatsu; 2011 Nov; 43(6):453-8. PubMed ID: 22180960
[TBL] [Abstract][Full Text] [Related]
18. Lamotrigine as an add-on drug in typical absence seizures.
Ferrie CD; Robinson RO; Knott C; Panayiotopoulos CP
Acta Neurol Scand; 1995 Mar; 91(3):200-2. PubMed ID: 7793236
[TBL] [Abstract][Full Text] [Related]
19. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group.
Duchowny M; Pellock JM; Graf WD; Billard C; Gilman J; Casale E; Womble G; Risner M; Manasco P
Neurology; 1999 Nov; 53(8):1724-31. PubMed ID: 10563619
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
